Follow the people · Insider
John M. Evans
John M. Evans files insider transactions with the SEC as a ceo of Beam Therapeutics (BEAM). We hold 7 disclosed purchases and sales filed since 17 August 2020, 2 of them in the last 90 days.
- Files forBEAM
- Disclosed buys and sells7 in all, 2 in the last 90 days
- Last disclosure1 July 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 5 February 2020 — 30 June 2026CEO · Beam Therapeutics (BEAM)178 Form 4 lines · source: SEC Form 4
- Filed 9 June 2022 — 9 June 2022Director · Verve Therapeutics (VERV)1 Form 4 line · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,663 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 30 June 2026 · filed 1 July 2026
- exercised options over 6,337 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 13,421 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 11,579 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▼ sold on the open market 23,100 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- ▼ sold on the open market 1,900 shares of Beam TherapeuticsSEC Form 41 July 2026Common Stock · traded 30 June 2026 · filed 1 July 2026
- exercised options over 18,663 shares of Beam Therapeutics (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 29 June 2026 · filed 1 July 2026
- exercised options over 6,337 shares of Beam Therapeutics (a derivative holding)SEC Form 41 July 2026Stock Option (Right to Buy) · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 30,078 shares of Beam TherapeuticsSEC Form 46 April 2026Common Stock · traded 1 April 2026 · filed 6 April 2026
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 41 April 2026Common Stock · traded 30 March 2026 · filed 1 April 2026
- ▼ sold on the open market 25,000 shares of Beam TherapeuticsSEC Form 41 April 2026Common Stock · traded 30 March 2026 · filed 1 April 2026
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- ▼ sold on the open market 25,000 shares of Beam TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- was granted 90,000 shares of Beam TherapeuticsSEC Form 41 April 2026Common Stock · traded 31 March 2026 · filed 1 April 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 30 March 2026 · filed 1 April 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 41 April 2026Stock Option (Right to Buy) · traded 31 March 2026 · filed 1 April 2026
- exercised options over 19,336 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 30 January 2026 · filed 2 February 2026
- was granted 180,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 31 January 2026 · filed 2 February 2026
- exercised options over 5,664 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 16,333 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 19,336 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- exercised options over 5,664 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 30 January 2026 · filed 2 February 2026
- was granted 180,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 31 January 2026 · filed 2 February 2026
- ▼ sold on the open market 8,667 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- ▼ sold on the open market 22,094 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2,906 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- exercised options over 19,336 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- exercised options over 19,336 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 5,664 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 16,333 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- ▼ sold on the open market 8,667 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 29 January 2026 · filed 2 February 2026
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- ▼ sold on the open market 22,094 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- ▼ sold on the open market 2,906 shares of Beam TherapeuticsSEC Form 42 February 2026Common Stock · traded 30 January 2026 · filed 2 February 2026
- exercised options over 5,664 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 2 February 2026
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 43 October 2025Stock Option (Right to Buy) · traded 1 October 2025 · filed 3 October 2025
- exercised options over 25,000 shares of Beam Therapeutics (a derivative holding)SEC Form 43 October 2025Stock Option (Right to Buy) · traded 2 October 2025 · filed 3 October 2025
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- ▼ sold on the open market 25,000 shares of Beam TherapeuticsSEC Form 43 October 2025Common Stock · traded 1 October 2025 · filed 3 October 2025
- exercised options over 25,000 shares of Beam TherapeuticsSEC Form 43 October 2025Common Stock · traded 2 October 2025 · filed 3 October 2025
- ▼ sold on the open market 25,000 shares of Beam TherapeuticsSEC Form 43 October 2025Common Stock · traded 2 October 2025 · filed 3 October 2025
- ▼ sold on the open market 30,663 shares of Beam TherapeuticsSEC Form 43 April 2025Common Stock · traded 1 April 2025 · filed 3 April 2025
- exercised options over 30,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 April 2025Stock Option (Right to Buy) · traded 30 January 2025 · filed 2 April 2025
- exercised options over 30,000 shares of Beam TherapeuticsSEC Form 42 April 2025Common Stock · traded 30 January 2025 · filed 2 April 2025
- was granted 77,500 shares of Beam TherapeuticsSEC Form 42 April 2025Common Stock · traded 31 March 2025 · filed 2 April 2025
- was granted 155,000 shares of Beam Therapeutics (a derivative holding)SEC Form 43 February 2025Stock Option (Right to Buy) · traded 31 January 2025 · filed 3 February 2025
- ▼ sold on the open market 29,800 shares of Beam TherapeuticsSEC Form 43 February 2025Common Stock · traded 30 January 2025 · filed 3 February 2025
- ▼ sold on the open market 200 shares of Beam TherapeuticsSEC Form 43 February 2025Common Stock · traded 30 January 2025 · filed 3 February 2025
- ▼ sold on the open market 60,000 shares of Beam TherapeuticsSEC Form 42 October 2024Common Stock · traded 30 September 2024 · filed 2 October 2024
- ▼ sold on the open market 60,000 shares of Beam TherapeuticsSEC Form 428 June 2024Common Stock · traded 27 June 2024 · filed 28 June 2024
- was granted 99,336 shares of Beam Therapeutics (a derivative holding)SEC Form 43 April 2024Stock Option (Right to Buy) · traded 3 April 2024 · filed 3 April 2024
- was granted 53,965 shares of Beam Therapeutics (a derivative holding)SEC Form 43 April 2024Stock Option (Right to Buy) · traded 3 April 2024 · filed 3 April 2024
- ▼ sold on the open market 18,102 shares of Beam TherapeuticsSEC Form 43 April 2024Common Stock · traded 1 April 2024 · filed 3 April 2024
- ▼ sold on the open market 60,000 shares of Beam TherapeuticsSEC Form 41 April 2024Common Stock · traded 28 March 2024 · filed 1 April 2024
- was granted 77,500 shares of Beam TherapeuticsSEC Form 41 April 2024Common Stock · traded 31 March 2024 · filed 1 April 2024
- was granted 155,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2024Stock Option (Right to Buy) · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 60,000 shares of Beam TherapeuticsSEC Form 42 February 2024Common Stock · traded 31 January 2024 · filed 2 February 2024
- ▼ sold on the open market 5,161 shares of Beam TherapeuticsSEC Form 45 April 2023Common Stock · traded 3 April 2023 · filed 5 April 2023
- ▼ sold on the open market 6,493 shares of Beam TherapeuticsSEC Form 45 April 2023Common Stock · traded 4 April 2023 · filed 5 April 2023
- was granted 112,500 shares of Beam Therapeutics (a derivative holding)SEC Form 431 March 2023Stock Option (Right to Buy) · traded 31 January 2023 · filed 31 March 2023
- exercised options over 13,850 shares of Beam Therapeutics (a derivative holding)SEC Form 431 March 2023Stock Option (Right to Buy) · traded 31 March 2023 · filed 31 March 2023
- received in a small acquisition of 225 shares of Beam TherapeuticsSEC Form 431 March 2023Common Stock · traded 6 March 2023 · filed 31 March 2023
- was granted 56,250 shares of Beam TherapeuticsSEC Form 431 March 2023Common Stock · traded 31 March 2023 · filed 31 March 2023
- exercised options over 13,850 shares of Beam TherapeuticsSEC Form 431 March 2023Common Stock · traded 31 March 2023 · filed 31 March 2023
- ▼ sold on the open market 7,567 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 7,768 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 11,756 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 2,909 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 5,008 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 4,569 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 8,235 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 2,188 shares of Beam TherapeuticsSEC Form 42 November 2022Common Stock · traded 31 October 2022 · filed 2 November 2022
- ▼ sold on the open market 10,181 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 15,236 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 1,562 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 2,848 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 173 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 6,953 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 10,599 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 201 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- ▼ sold on the open market 2,247 shares of Beam TherapeuticsSEC Form 429 July 2022Common Stock · traded 28 July 2022 · filed 29 July 2022
- was granted 15,500 shares of Verve Therapeutics (a derivative holding)SEC Form 413 June 2022Stock Option (right to buy) · traded 9 June 2022 · filed 13 June 2022
- exercised options over 12,246 shares of Beam Therapeutics (a derivative holding)SEC Form 42 May 2022Stock Option (Right to Buy) · traded 28 April 2022 · filed 2 May 2022
- exercised options over 47,204 shares of Beam Therapeutics (a derivative holding)SEC Form 42 May 2022Stock Option (Right to Buy) · traded 28 April 2022 · filed 2 May 2022
- exercised options over 12,246 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- exercised options over 47,204 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 3,900 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 13,655 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 6,842 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 4,503 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 1,100 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 6,450 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 7,745 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 3,100 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 2,348 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- ▼ sold on the open market 357 shares of Beam TherapeuticsSEC Form 42 May 2022Common Stock · traded 28 April 2022 · filed 2 May 2022
- was granted 56,250 shares of Beam TherapeuticsSEC Form 44 April 2022Common Stock · traded 31 March 2022 · filed 4 April 2022
- ▼ sold on the open market 6,261 shares of Beam TherapeuticsSEC Form 44 April 2022Common Stock · traded 31 March 2022 · filed 4 April 2022
- exercised options over 100,000 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2022Stock Option (Right to Buy) · traded 31 January 2022 · filed 2 February 2022
- was granted 112,500 shares of Beam Therapeutics (a derivative holding)SEC Form 42 February 2022Stock Option (Right to Buy) · traded 31 January 2022 · filed 2 February 2022
- gave away 12,000 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 16 November 2021 · filed 2 February 2022
- ▼ sold on the open market 801 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 2,172 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 3,177 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 6,337 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 13,535 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 3,978 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- exercised options over 100,000 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 300 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 1,615 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 1,900 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 4,105 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 9,408 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- ▼ sold on the open market 2,672 shares of Beam TherapeuticsSEC Form 42 February 2022Common Stock · traded 31 January 2022 · filed 2 February 2022
- exercised options over 27,700 shares of Beam Therapeutics (a derivative holding)SEC Form 48 October 2021Stock Option (Right to Buy) · traded 6 October 2021 · filed 8 October 2021
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.